Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

✍ Scribed by Black, H R; Graff, A; Shute, D; Stoltz, R; Ruff, D; Levine, J; Shi, Y; Mallows, S

• Book ID: 110047644
• Publisher: Nature Publishing Group
• Year: 1997
• Tongue: English
• Weight: 272 KB
• Volume: 11
• Category: Article
• ISSN: 0950-9240
• DOI: 10.1038/sj.jhh.1000482